AMENDMENT
TO CONSULTANT AGREEMENT








 


This
Amendment (this “Amendment”) to the Consultant Agreement (the “Agreement”) is entered into
effective as of August 1, 2019, between PURE Bioscience, Inc., a Delaware corporation (the “Company”), and
Dave Pfanzelter (“Consultant”). Capitalized terms used but not defined herein shall have the meanings ascribed
to such terms in the Agreement.


 


WHEREAS,
the Company and Consultant entered into the Agreement effective as of August 13, 2018;


 


WHEREAS,
under the Agreement, Consultant performed consulting services to the Board of Directors (the “Board”) of the
Company;


 


WHEREAS,
Consultant desires to continue performing consulting services to the Board, and is willing to continue performing such services
on the terms and conditions set forth in the Agreement, as amended by this Amendment;


 


WHEREAS,
the Company and the Board have determined that it is in the best interest of the Company and its stockholders to amend the Agreement
as set forth herein; and


 


WHEREAS,
Section 10 (Amendment) of the Agreement provides that the Agreement may be amended in writing in an amendment entered into between
the parties.


 


NOW,
THEREFORE, in consideration of the mutual covenants contained in this Amendment and other good and valuable consideration, the
Company and Consultant agree as follows:


 


1.
The Agreement is hereby amended by deleting Section 3.2 (Compensation) of the Agreement and replacing it with the following paragraph:


 


“3.2
Compensation. Commencing as of the Effective Date, the Company shall pay the Consultant $100 per hour for services pursuant
to this Agreement, payable on a monthly basis (the “Consultant Compensation”).”


 


2.
This Amendment shall prevail and control with respect to any inconsistency between the provisions of this Amendment and the provisions
of the Agreement.


 


3.
This Amendment constitutes an amendment to the Agreement and, except as expressly amended, supplemented or modified in this Amendment,
all provisions of the Agreement remain in full force and effect.


 


4.
This Amendment and the Agreement, including any attachments or exhibits incorporated by reference, is the entire agreement between
the parties with respect to the subject matter hereof and supersedes all prior or contemporaneous oral or written communications,
proposals, agreements, conditions, warranties or representations with respect to the subject matter hereof and prevails over any
conflicting or additional terms of any communication between the parties relating to the subject matter hereof during the Term.


 


5.
This Amendment may be executed in counterparts, each of which so executed shall be deemed to be an original and such counterparts
together will constitute one and the same instrument. In addition, the parties agree that documents executed and transmitted by
facsimile, transmitted electronically with electronic or digital signature, or transmitted by email with a scanned copy shall
be deemed to be an original signature for purposes of this Amendment.


 










[Remainder
of page intentionally left blank.]


 




    	 	1	 



    	 



    


 


IN
WITNESS WHEREOF, the undersigned are duly authorized to execute this Amendment.


 





	PURE BIOSCIENCE, INC.	 	 	CONSULTANT
	 	 	 	 	 
	By:	/s/
    Henry R. Lambert	 	By:
    	/s/
    Dave Pfanzelter
	Name:	Henry
    R. Lambert	 	 	Dave
    Pfanzelter
	Title:
    	Chief
    Executive Officer	 	 	 


 




    	 	2